5-110746313-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_138773.4(SLC25A46):c.429C>T(p.Val143Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00984 in 1,592,252 control chromosomes in the GnomAD database, including 402 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.030 ( 194 hom., cov: 32)
Exomes 𝑓: 0.0077 ( 208 hom. )
Consequence
SLC25A46
NM_138773.4 synonymous
NM_138773.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.329
Genes affected
SLC25A46 (HGNC:25198): (solute carrier family 25 member 46) This gene encodes a mitochondrial solute carrier protein family member. It functions in promoting mitochondrial fission, and prevents the formation of hyperfilamentous mitochondria. Mutation of this gene results in neuropathy and optic atrophy. [provided by RefSeq, Aug 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.38).
BP6
Variant 5-110746313-C-T is Benign according to our data. Variant chr5-110746313-C-T is described in ClinVar as [Benign]. Clinvar id is 475796.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-110746313-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.329 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0914 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC25A46 | NM_138773.4 | c.429C>T | p.Val143Val | synonymous_variant | 4/8 | ENST00000355943.8 | NP_620128.1 | |
SLC25A46 | NM_001303249.3 | c.429C>T | p.Val143Val | synonymous_variant | 4/8 | NP_001290178.1 | ||
SLC25A46 | NM_001303250.3 | c.156C>T | p.Val52Val | synonymous_variant | 4/8 | NP_001290179.1 | ||
SLC25A46 | NR_138151.2 | n.542C>T | non_coding_transcript_exon_variant | 4/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A46 | ENST00000355943.8 | c.429C>T | p.Val143Val | synonymous_variant | 4/8 | 1 | NM_138773.4 | ENSP00000348211.3 |
Frequencies
GnomAD3 genomes AF: 0.0303 AC: 4606AN: 152086Hom.: 193 Cov.: 32
GnomAD3 genomes
AF:
AC:
4606
AN:
152086
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00973 AC: 2238AN: 229912Hom.: 70 AF XY: 0.00812 AC XY: 1015AN XY: 125030
GnomAD3 exomes
AF:
AC:
2238
AN:
229912
Hom.:
AF XY:
AC XY:
1015
AN XY:
125030
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00768 AC: 11059AN: 1440050Hom.: 208 Cov.: 28 AF XY: 0.00722 AC XY: 5172AN XY: 716524
GnomAD4 exome
AF:
AC:
11059
AN:
1440050
Hom.:
Cov.:
28
AF XY:
AC XY:
5172
AN XY:
716524
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0303 AC: 4613AN: 152202Hom.: 194 Cov.: 32 AF XY: 0.0288 AC XY: 2141AN XY: 74416
GnomAD4 genome
AF:
AC:
4613
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
2141
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3468
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Neuropathy, hereditary motor and sensory, type 6B Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at